Cardiovascular effects and mortality of short-acting bronchodilators in asthma and COPD
Aug 31, 2026

Increased use of SAMA or SABA+SAMA was associated with increased risks of cardiovascular events and mortality in patients with asthma and COPD. Collecting ≥3 SABA canisters/year was associated with increased mortality.


Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.

Over 6000+ more articles available in the Professional Education Portal.

Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.

Access this free resource